Abstract
The renin-angiotensin system (RAS) consists of a complex enzyme-peptide system, which, besides from functioning as a circulating endocrine system, is also intrinsic in many organs and tissues, including the brain. Although the RAS generates a family of biological active peptides, angiotensin II (Ang II) is still considered one of its main mediators and effectors. Ang II produces many well defined and potent effects through AT1 and AT2 receptors and its physiological applications are yet expanding. Recently, it has been proposed that Ang II, acting both centrally and peripherally, interferes on exercise performance due to its influence on multiple functions within the organism. This hypothesis is also supported by evidences reporting an increased frequency of the ACE I allele among elite athletes, suggesting that this is a genetic factor that influences physical performance. The fatigue resulting from physical exercise is a multifactorial phenomenon that comprises the interaction between physiological factors of peripheral and/or central origin. To that extent, the Ang II-mediated events on factors that affect exercise performance such as cardiovascular, metabolic and thermoregulatory adjustments as well as cerebral metabolism and neurohumoral or neurotransmitter turnover, implicate the peptide in the genesis of exercise-induced fatigue. This mini-review focuses on how exercise-induced physiological adjustments are influenced by Ang II within the central nervous system and how these effects may limit athletic performance.
Keywords: Renin-angiotensin system, AT1 receptor, thermoregulation, metabolic cost, blood pressure, exercise central fatigue.
Current Protein & Peptide Science
Title:Implications of Angiotensin II in Central Nervous System on Exercise Performance
Volume: 14 Issue: 8
Author(s): Laura H. R. Leite, Henrique P. Santiago, Rafael S. V. de Almeida and Cândido C. Coimbra
Affiliation:
Keywords: Renin-angiotensin system, AT1 receptor, thermoregulation, metabolic cost, blood pressure, exercise central fatigue.
Abstract: The renin-angiotensin system (RAS) consists of a complex enzyme-peptide system, which, besides from functioning as a circulating endocrine system, is also intrinsic in many organs and tissues, including the brain. Although the RAS generates a family of biological active peptides, angiotensin II (Ang II) is still considered one of its main mediators and effectors. Ang II produces many well defined and potent effects through AT1 and AT2 receptors and its physiological applications are yet expanding. Recently, it has been proposed that Ang II, acting both centrally and peripherally, interferes on exercise performance due to its influence on multiple functions within the organism. This hypothesis is also supported by evidences reporting an increased frequency of the ACE I allele among elite athletes, suggesting that this is a genetic factor that influences physical performance. The fatigue resulting from physical exercise is a multifactorial phenomenon that comprises the interaction between physiological factors of peripheral and/or central origin. To that extent, the Ang II-mediated events on factors that affect exercise performance such as cardiovascular, metabolic and thermoregulatory adjustments as well as cerebral metabolism and neurohumoral or neurotransmitter turnover, implicate the peptide in the genesis of exercise-induced fatigue. This mini-review focuses on how exercise-induced physiological adjustments are influenced by Ang II within the central nervous system and how these effects may limit athletic performance.
Export Options
About this article
Cite this article as:
Leite H. R. Laura, Santiago P. Henrique, de Almeida S. V. Rafael and Coimbra C. Cândido, Implications of Angiotensin II in Central Nervous System on Exercise Performance, Current Protein & Peptide Science 2013; 14 (8) . https://dx.doi.org/10.2174/1389203711209070672
DOI https://dx.doi.org/10.2174/1389203711209070672 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alcoholisms Evolutionary and Cultural Origins
Current Drug Abuse Reviews Gender-Specific Aspects in Primary and Secondary Prevention of Cardiovascular Disease
Current Pharmaceutical Design COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact
Current Pharmaceutical Design Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
Current Diabetes Reviews Preoperative Plasma Aldosterone Levels and Postoperative Atrial Fibrillation Occurrence Following Cardiac Surgery: A Review of Literature and Design of the ALDO-POAF Study (ALDOsterone for Prediction of Post-Operative Atrial Fibrillation)
Current Clinical Pharmacology ADP Receptors-Targets for Developing Antithrombotic Agents
Current Pharmaceutical Design The Role of Vitamin D in Atherosclerosis Inflammation Revisited: More a Bystander than a Player?
Current Vascular Pharmacology Pharmacotherapies to Manage Bone Loss-Associated Diseases: A Quest for the Perfect Benefit-to-Risk Ratio
Current Medicinal Chemistry AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Current Alzheimer Research Human Immunodeficiency Virus-Mononuclear Phagocyte Interactions:Emerging Avenues of Biomarker Discovery, Modes of Viral Persistence and Disease Pathogenesis
Current HIV Research Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Heart Rate Variability Analysis at Coronary Artery Disease and Angina Pectoris
Recent Patents on Cardiovascular Drug Discovery Clozapine Safety, 40 Years Later
Current Drug Safety Barriers to Achieving Optimal Glycemic Control in a Multi-Ethnic Society: A US Focus
Current Diabetes Reviews Clinical Applications of Cardiac Multi-Slice Computed Tomography
Current Medical Imaging Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies
Current Clinical Pharmacology Statins: The Holy Grail of Abdominal Aortic Aneurysm (AAA) Growth Attenuation? A Systematic Review of the Literature
Current Vascular Pharmacology Autologous Adipose-Derived Regenerative Cells for Therapeutic Angiogenesis
Current Pharmaceutical Design Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development
Current Cancer Drug Targets Smoking and Endothelial Progenitor Cells: A Revision of Literature
Current Pharmaceutical Design